Condition
Acute Traumatic Pain
Total Trials
5
Recruiting
0
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
100%
5 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
P 3 (5)
Trial Status
Completed3
Active Not Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02866071Phase 3Active Not RecruitingPrimary
Intranasal Ketamine as an Adjunct to Fentanyl for the Prehospital Treatment of Acute Traumatic Pain
NCT04618497Phase 3CompletedPrimary
A Pilot Study on the Use of Methoxyflurane (Penthrox®) for Pain Control in the Emergency Department
NCT03511833Phase 3UnknownPrimary
Comparison of Treatment by IN Ketamine to IV Morphine in Acute Pain
NCT03585374Phase 3CompletedPrimary
Trauma Acute Pain Treatment With Methoxyflurane Vaporized (PENTHROX®): Efficacy and Safety Study (MEDITA)
NCT01731184Phase 3CompletedPrimary
Morphine-Midazolam in Pre-hospital Traumatic Patients With Severe Acute Pain
Showing all 5 trials